| Application no. and date | 18213451.0 (espacenet) (Federated) (European Patent Register), 20121003 | | Patent/reg. no. and date | DK/EP 3492109, 20200304 | | Publication date | 20190605 | | Priority no. and date | US 201161542533 P, 20111003 | | EP pub. no. and date |
EP 3492109 20190605 | | Effective date | | | Applicant/owner | ModernaTX, Inc., 200 Technology Square
Cambridge, MA 02139, US | | Applicant ref. no. | | | Inventor | DE FOUGEROLLES, Antonin, 66 Summit Avenue
Brookline, MA 02446, US,
Siddiqi, Suhaib, 37 University Avenue
Burlington, MA 01803, US,
ROY, Atanu, 115 Hill Street 9
Stoneham, MA 02180, US,
HATALA, Paul, 26 Monument Street 1
Charlestown, MA 02124, US,
BANCEL, Stephane, c/o Moderna Therapeutics, Inc.
320 Bent Street
Cambridge, MA 02141, US,
Schrum, Jason P., 20 Watertown St.
Unit 129
Watertown, MA 02472-2580, US | | Representative | | | Opponent | | | IPC Class | A61K 48/00 (2006.01) , C07H 21/02 (2006.01) , C07H 21/04 (2006.01) | | Title | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
